Meningitis b vaccine shows promise in children
NCT ID NCT01054053
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how well the MenBVac vaccine protects children against a specific type of meningitis B bacteria. Researchers measured the immune response in 218 children who had already received five doses of the vaccine. The goal was to see if the children had enough antibodies to fight off the infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VACCINATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Maison Du Département
Neufchâtel-en-Bray, 76270, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hospital push could shield seniors from preventable diseases
- Teens' sleep habits may boost vaccine power
- Simple exercise test may reveal hidden risks in flu patients
- Nutrient sachets may boost vaccination rates in rural africa
- Text reminders help get young kids vaccinated on time
- Mpox vaccine trial for infants: could a Half-Dose protect just as well?